BDBM1588 2-cyclopropyl-7-(pyrrolidin-1-ylmethyl)-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one::Nevirapin 4-substituted deriv. 4k::ll-Cyclopropyl-5,ll-dihydro-4-( 1-pyrrolidinylmethy1)-6H-dipyrido[3,2-b:2 ,3 -e][ 1,4]diazepin-6-one
SMILES: O=C1Nc2c(CN3CCCC3)ccnc2N(C2CC2)c2ncccc12
InChI Key: InChIKey=DSXLYCCTCAHHJC-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIV-1 Reverse Transcriptase (Human immunodeficiency virus type 1) | BDBM1588 (2-cyclopropyl-7-(pyrrolidin-1-ylmethyl)-2,4,9,15-t...) | PDB MMDB B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 700 | n/a | n/a | n/a | n/a | 7.8 | 22 |
Boehringer Ingelheim Pharmaceuticals Inc. | Assay Description The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro. | J Med Chem 38: 4839-47 (1995) Article DOI: 10.1021/jm00024a011 BindingDB Entry DOI: 10.7270/Q2ZK5DV7 | |||||||||||
More data for this Ligand-Target Pair |